BILL ANALYSIS                                                                                                                                                                                                    Ó



                                                                  AB 1442
                                                                  Page 1


          ASSEMBLY THIRD READING
          AB 1442 (Wieckowski)
          As Amended  March 27, 2012
          Majority vote 

           ENVIRONMENTAL SAFETY         8-0APPROPRIATIONS      17-0        
           
           ----------------------------------------------------------------- 
          |Ayes:|Wieckowski, Miller,       |Ayes:|Fuentes, Harkey,          |
          |     |Campos, Chesbro, Davis,   |     |Blumenfield, Bradford,    |
          |     |Donnelly, Feuer, Morrell  |     |Charles Calderon, Campos, |
          |     |                          |     |Davis, Donnelly, Gatto,   |
          |     |                          |     |Ammiano, Hill, Lara,      |
          |     |                          |     |Mitchell, Nielsen, Norby, |
          |     |                          |     |Solorio, Wagner           |
          |     |                          |     |                          |
           ----------------------------------------------------------------- 
           SUMMARY  :  Authorizes the transportation of pharmaceutical waste, 
          as defined, by a common carrier.  Specifically,  this bill  :

          1)Defines "common carrier" as either of the following:

             a)   A person or company that has a United States Department 
               of Transportation number issued by the Federal Motor 
               Carrier Safety Administration and is registered with the 
               Federal Motor Carrier Safety Administration as a for-hire 
               property carrier.

             b)   A person or company that has a motor carrier of property 
               permit issued by the Department of Motor Vehicles pursuant 
               to the Motor Carriers of Property Permit Act and, if 
               applicable, a carrier identification number issued by the 
               Department of the California Highway Patrol.

          2)Defines "pharmaceutical waste" as any pharmaceutical that for 
            any reason may no longer be sold or dispensed for use as a 
            drug.  Excludes from this definition those pharmaceuticals 
            that still have potential value to the generator because they 
            are being returned to a reverse distributor for possible 
            manufacturer credit.

          3)Authorizes a medical waste generator or parent organization 
            that employs health care professionals who generate 
            pharmaceutical waste to apply to the enforcement agency for a 








                                                                  AB 1442
                                                                  Page 2


            pharmaceutical waste hauling exemption if the generator, 
            health care professional, or parent organization meets all of 
            the following requirements:

             a)   The generator or parent organization has on file one of 
               the following:

               i)     If the generator or parent organization is a small 
                 quantity generator required to register with the 
                 enforcement agency, the required medical waste management 
                 plan, as defined in statute.

               ii)    If the generator or parent organization is a small 
                 quantity generator not required to register, the 
                 information document, as defined in statute.

               iii)   If the generator or parent organization is a large 
                 quantity generator, a medical waste management plan, as 
                 defined in statute.

             b)   The generator or health care professional who generated 
               the pharmaceutical waste transports the pharmaceutical 
               waste himself or herself, or directs a member of his or her 
               staff to transport the pharmaceutical waste to a parent 
               organization or another health care facility for the 
               purpose of consolidation before treatment and disposal, or 
               contracts with a common carrier to transport the 
               pharmaceutical waste to a permitted medical waste treatment 
               facility or transfer station.

             c)   The generator and the facility receiving the medical 
               waste maintain a tracking document, as defined in statute.

             d)   The health care professional who generates and returns 
               the pharmaceutical waste to the parent organization for the 
               purpose of consolidation before treatment and disposal is 
               authorized to substitute a single-page form or multiple 
               entry log for the tracking document if the form or log 
               contains specified information.

          4)Clarifies that this bill does not prohibit the use of a single 
            document to verify the return of more than one container to a 
            parent organization or another health care facility for the 
            purpose of consolidation before treatment and disposal over a 








                                                                  AB 1442
                                                                  Page 3


            period of time, if the form or log is maintained in the files 
            of the parent organization or another health care facility 
            that receives the waste once the form or log is completed. 

          5)Requires the form or log to be maintained in the files of the 
            health care professional who generates the pharmaceutical 
            waste and the parent organization or another health care 
            facility that receives the waste.

          6)Makes other conforming changes.
           
          FISCAL EFFECT  :   According to the Assembly Appropriations 
          Committee, enactment of this bill would have the following 
          fiscal effect:

          1)Annual special fund costs of approximately $280,000 
            (equivalent to three positions) in 2012-13 through 2014-15 to 
            the California Department of Public Health (CDPH)-the state 
            agency that enforces medical waste transport-to coordinate 
            with stakeholders statewide, oversee rulemaking process and 
            develop regulations.  

          2)Annual special fund costs of approximately $159,000 
            (equivalent to two positions) to the department to review 
            exemption requests and ensure compliance with documentation 
            requirements. 

           COMMENTS  :

           Need for the bill  :  According to the author, "Under existing 
          law, pharmaceutical drugs can be sent to health care facilities 
          through standard common carriers, or standard shipping means.  
          Unused drugs can sometimes be returned to the manufacturer for 
          credit, via a common carrier.  Expired and non-dispensable drugs 
          must be shipped as "Medical Waste," requiring expensive 
          hazardous waste shipping, instead of common carrier.  This is 
          unnecessarily expensive for pharmacies, hospitals, and other 
          health care facilities, who are simply returning the exact same 
          drug that was shipped to them by common carrier."
           
          Regulation of pharmaceutical waste under the Medical Waste 
          Management Act (MWMA)  :  Pharmaceutical wastes that must be 
          managed according to the MWMA are those that are classified as 
          "California only hazardous waste" by Chapter 11, Title 22, 








                                                                  AB 1442
                                                                  Page 4


          California Code of Regulations.  If a pharmaceutical waste meets 
          the criteria of a California hazardous waste, it must be 
          segregated in an appropriate container, properly labeled, 
          stored, manifested, transported and incinerated at a regulated 
          medical waste incinerator or destroyed through another method 
          approved by the CDPH.  The MWMA prohibits a person from hauling 
          medical waste unless the person is either a registered hazardous 
          waste hauler or has an approved limited-quantity exemption.

           Reverse distribution and transporting pharmaceutical waste  :  It 
          is common practice for pharmacies and other health care 
          facilities to return unused pharmaceuticals to the manufacturer 
          for credit or disposal.  Health care facilities have the option 
          of hiring reverse distributors to manage their unused and/or 
          expired medication that could be returned to the manufacturer or 
          wholesaler for credit.  The reverse distributor determines which 
          medications may be returned to the manufacturer or wholesaler 
          for credit and arranges for disposal of unused medications that 
          are waste.  Once the unused pharmaceutical is determined to be 
          ineligible for credit, it becomes waste and must be managed as 
          such.

          In California, reverse distributors are regulated by both the 
          Board of Pharmacy (BOP) and the CDPH.  The BOP regulates 
          activities involving "dangerous drugs," as defined in Business 
          and Professions Code (BPC) Section 4022, which includes 
          prescription medications.  Reverse distributors that intend to 
          receive "outdated or nonsalable dangerous drugs," which could 
          include potentially creditable drugs, must register with the BOP 
          as "drug wholesalers" (BPC Sections 4040.5, 4043 and 4160).  
          However, once a pharmaceutical is designated as "medical waste" 
          pursuant to the MWMA, it is regulated by the CDPH (HSC Section 
          117690).  For purposes of the MWMA, the term "pharmaceutical" 
          isn't restricted to "dangerous drugs" as set forth in the BPC, 
          but rather is intended to cover all pharmaceuticals, including 
          both prescription and over-the-counter drugs (HSC Section 
          117747).

          The MWMA requires that medical waste pharmaceuticals be sent to 
          reverse distributors via a licensed hazardous waste hauler (HSC 
          Section 118000).  However, according to DPH's Self-Assessment 
          Manual for Proper Management of Medical Waste, pharmaceuticals 
          that have "intrinsic value" (such as outdated or otherwise 
          unsalable pharmaceuticals that are returned for credit) are not 








                                                                  AB 1442
                                                                  Page 5


          considered "waste" and, thus, may be shipped to a reverse 
          distributor via a common carrier.  Therefore, under current law, 
          whether or not a pharmaceutical is creditable determines whether 
          it must be transported via a registered waste hauler or is 
          authorized to be transported via common carrier.  As is 
          authorized under current law for outdated or otherwise unsalable 
          creditable pharmaceuticals, this bill authorizes the 
          transportation of outdated or otherwise unsalable non-creditable 
          pharmaceuticals, which are designated as medical waste, via a 
          common carrier.

           
          Analysis Prepared by  :    Shannon McKinney / E.S. & T.M. / (916) 
          319-3965 


                                                                FN: 0003861